Yukiharu Inui

4.6k citations
20 papers · 3.9k indexed · 1 hit paper · h-index 13
Topics
Pharmacogenetics and Drug Metabolism (4 papers)Amino Acid Enzymes and Metabolism (3 papers)Carcinogens and Genotoxicity Assessment (3 papers)
Partner nations
JapanUnited States

In The Last Decade

Yukiharu Inui

20 papers receiving 3.7k citations

Hit Papers

Interindividual variations in human liver cytochrome P-45...1994202620042015199450010001.5k2.0k

Peers

Yukiharu Inui
Comparison fields: 5 of 124
  • Pharmacology 2.4k
  • Oncology 1.3k
  • Molecular Biology 956
  • Epidemiology 485
  • Biochemistry 411
Replace Mayumi Mimura with:
Mayumi Mimura Japan
P. Kremers Belgium
Jorge Goldstein United States
Judy L. Raucy United States
Mark VandenBranden United States
Kenneth R. Korzekwa United States
Mikael Oscarson Sweden
Barbara J. Ring United States
Markku Pasanen Finland
F. Berthou France
Yukiharu Inui relative to Mayumi Mimura Japan Mayumi Mimura's profile →
Citations per field
00.5×4.8×
Mayumi Mimura · 1×
Citations per year

Countries citing papers authored by Yukiharu Inui

Since Specialization
Citations

This map shows the geographic impact of Yukiharu Inui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukiharu Inui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukiharu Inui more than expected).

Fields of papers citing papers by Yukiharu Inui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukiharu Inui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukiharu Inui. The network helps show where Yukiharu Inui may publish in the future.

Co-authorship network of co-authors of Yukiharu Inui

This figure shows the co-authorship network connecting the top 25 collaborators of Yukiharu Inui. A scholar is included among the top collaborators of Yukiharu Inui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukiharu Inui. Yukiharu Inui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 13
2 463
3 1
4 1
5
Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs.
204
6 50
7 2
8
Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.breakdown →
2366
9 26
10 91
11 80
12 331
13 14
14
An approach to the genesis of idiopathic cardiomyopathy.
1
15
Cardiomyopathy in vitro.
1
16
Morphological and biochemical studies on the heart of the cardiomyopathic Syrian hamster.
8
17 1
18 147
19 27
20 43

About Yukiharu Inui

Yukiharu Inui is a scholar working on Biochemistry, Pharmacology and Pharmaceutical Science, having authored 20 papers that have together received 3.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Amino Acid Enzymes and Metabolism (3 papers) and Carcinogens and Genotoxicity Assessment (3 papers). The work is most often cited by research in Pharmacology (2.4k citations), Biochemistry (411 citations) and Oncology (1.3k citations). Yukiharu Inui has collaborated with scholars based in Japan and United States. Frequent co-authors include Hiroshi Yamazaki, F. Peter Guengerich, Tsutomu Shimada, Mayumi Mimura, Halvor N. Christensen, Chul‐Ho Yun, M. Nishida, Masahiro Muraguchi, Y. Arita and Tadashi Nakamura. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Carcinogenesis and The Journal of General Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026